When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4 lymphocyte counts <350 cells/µL

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalInfectious Diseases in Clinical Practice
Volume12
Issue number3
DOIs
StatePublished - Jan 1 2004

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this